Since the start of clinical trials for its device, this company has seen a steady increase in trading volume. Momentum is building as the company becomes closer to possible FDA approval & we have the FULL details! Full Report, HERE!
It was today that Salesforce.com, Inc (NYSE:CRM) proceeded to make the announcement regarding its recent move to be delivering about 1 billion AI-driven predictions to all its customers on a daily basis. Fundamentally, much of these predictions are given a major lift by Salesforce’s Einstein-branded capabilities, which include service and sales forecasting…Read More Now
Baxter International Inc (NYSE:BAX) reported a quarterly cash payout and an extended authorization for its share repurchase plan. The Board has announced a quarterly cash payout of $0.16 a share of common stock, to be paid on April 2, 2018, to shareholders as of record date March 2, 2018. The indicated yearly dividend rate is $0.64 a share of common stock…Read More Now